Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for sexual dysfunction in female multiple sclerosis patients
IRCT20140105016087N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupropion in sexual dysfunction and multiple sclerosis (MS), sponsored by Mazandaran University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
bupropion
03
Conditions
sexual dysfunctionmultiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20140105016087N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140105016087N2.